Work

CD40 ligand (CD40L) multi-trimer antigen fusion protein (MagaVax) as a vaccine design for high-level CD8+ T cell responses

Year: 2019

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.202.supp.196.6

Authors: Richard S Kornbluth, Christopher Adase, Victoria Snarsky Hamilton, Sean Studer

Institution: Multimeric Biotherapeutics (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313365836

Cites:

Cited by: 1

Related to: 10